Building More Predictive Preclinical Strategies for Successful Clinical Translation

5:15 pm - Wednesday 20th January 2027

  • Discuss the importance of preclinical model selection and data quality in improving translation from preclinical studies to human trials
  • Explore how endpoint selection should be scientifically driven by the chosen preclinical model and aligned with clinically relevant features of the human disease
  • Examine how preclinical readouts can be evaluated for their relevance and predictive value in human trials, helping identify models with greater translational potential

Speakers:

Chief Scientific Officer
OKYO Pharma